De Novo Biosynthesis of Trigonelline in Engineered Escherichia coli
ACS Synthetic Biology · 19.06.2026 · 15 (6) · 2479-2489
DOI: 10.1021/acssynbio.6c00121 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Synthetic Biology, online erschienen am 20.05.2026. Verfasst von Yanqiao Xue und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230026, China. Hauptthemen laut MEDLINE: Escherichia coli, Alkaloids, Metabolic Engineering. Die Arbeit nennt 52 Literaturangaben. Gefördert von: Guangdong Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230026, China.
- Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin 300308, China.
- National Center of Technology Innovation for Synthetic Biology, Tianjin 300308, China.
- Key Laboratory of Engineering Biology for Low-carbon Manufacturing, Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin 300308, China.
- University of Chinese Academy of Sciences, Beijing 100049, China.
ORCID-Profile: Tao Liu
Förderung
- Guangdong Province
Zitieren
APA
Xue, Y., Liu, M., Tang, J., & Liu, T. (2026). De Novo Biosynthesis of Trigonelline in Engineered Escherichia coli. ACS Synthetic Biology, 15(6), 2479-2489. https://doi.org/10.1021/acssynbio.6c00121
Vancouver
Xue Y, Liu M, Tang J, Liu T. De Novo Biosynthesis of Trigonelline in Engineered Escherichia coli. ACS Synthetic Biology. 2026;15(6):2479-2489. doi:10.1021/acssynbio.6c00121
BibTeX
@article{Xue2026,
author = {Xue, Yanqiao and Liu, Moshi and Tang, Jun and Liu, Tao},
title = {De Novo Biosynthesis of Trigonelline in Engineered Escherichia coli},
journal = {ACS Synthetic Biology},
year = {2026},
volume = {15},
number = {6},
pages = {2479--2489},
doi = {10.1021/acssynbio.6c00121}
}
EUVIMED